These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 22105442)

  • 1. Absorption enhancers: applications and advances.
    Aungst BJ
    AAPS J; 2012 Mar; 14(1):10-8. PubMed ID: 22105442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications.
    Sahni JK; Chopra S; Ahmad FJ; Khar RK
    J Pharm Pharmacol; 2008 Sep; 60(9):1111-9. PubMed ID: 18718113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using peptides to increase transport across the intestinal barrier.
    Sánchez-Navarro M; Garcia J; Giralt E; Teixidó M
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):355-366. PubMed ID: 27155131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Penetration Enhancers for Transdermal Drug Delivery - Success and Challenges.
    Ita KB
    Curr Drug Deliv; 2015; 12(6):645-51. PubMed ID: 26239423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravail: highly effective intranasal delivery of peptide and protein drugs.
    Maggio ET
    Expert Opin Drug Deliv; 2006 Jul; 3(4):529-39. PubMed ID: 16822227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
    Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
    J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical penetration enhancers.
    Newton SJ
    Int J Pharm Compd; 2013; 17(5):370-4. PubMed ID: 24459781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmucosal Absorption Enhancers in the Drug Delivery Field.
    Maher S; Casettari L; Illum L
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31311173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral colon-specific drug delivery of protein and peptide drugs.
    Sinha V; Singh A; Kumar RV; Singh S; Kumria R; Bhinge J
    Crit Rev Ther Drug Carrier Syst; 2007; 24(1):63-92. PubMed ID: 17430100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced Approaches of Bioactive Peptide Molecules and Protein Drug Delivery Systems.
    Thotakura N; Kaushik L; Kumar V; Preet S; Babu PV
    Curr Pharm Des; 2018; 24(43):5147-5163. PubMed ID: 30727874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption enhancers for nasal drug delivery.
    Davis SS; Illum L
    Clin Pharmacokinet; 2003; 42(13):1107-28. PubMed ID: 14531723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to improve intestinal and transmucosal absorption of peptide and protein drugs.
    Yamamoto A; Ukai H; Morishita M; Katsumi H
    Pharmacol Ther; 2020 Jul; 211():107537. PubMed ID: 32201316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-trimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery. Development and characterization of minitablet and granule formulations.
    van der Merwe SM; Verhoef JC; Kotzé AF; Junginger HE
    Eur J Pharm Biopharm; 2004 Jan; 57(1):85-91. PubMed ID: 14729083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Improvement of transmucosal absorption of biologically active peptide drugs].
    Yamamoto A
    Yakugaku Zasshi; 2001 Dec; 121(12):929-48. PubMed ID: 11766407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaches towards enhanced transepithelial drug delivery.
    Majumdar S; Mitra AK
    Discov Med; 2006 Dec; 6(36):229-33. PubMed ID: 17250788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials.
    Aguirre TA; Teijeiro-Osorio D; Rosa M; Coulter IS; Alonso MJ; Brayden DJ
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):223-241. PubMed ID: 26921819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excipients with specialized functions for effective drug delivery.
    Hamman J; Steenekamp J
    Expert Opin Drug Deliv; 2012 Feb; 9(2):219-30. PubMed ID: 22196483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Improvement of Intestinal and Transmucosal Absorption of Peptide and Protein Drugs].
    Yamamoto A
    Yakugaku Zasshi; 2024; 144(7):697-714. PubMed ID: 38945845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.